The origin of motor fluctuations in Parkinson's disease - Importance of dopaminergic innervation and basal ganglia circuits

被引:136
作者
Obeso, JA
Rodriguez-Oroz, M
Marin, C
Alonso, F
Zamarbide, I
Lanciego, JL
Rodriguez-Diaz, M
机构
[1] Univ Navarra, Clin Univ, FIMA, Dept Neurol & Neurosurg, Pamplona 31180, Spain
[2] Univ Navarra, Clin Univ, FIMA, Dept Histol,Neurosci Ctr, Pamplona, Spain
[3] Univ Navarra, Clin Univ, FIMA, Dept Histol,Neurosci Ctr, E-31080 Pamplona, Spain
[4] Univ Navarra, Sch Med, E-31080 Pamplona, Spain
[5] IDIBAG, Hosp Clin, Fundacio Clin, Expt Neurol Lab, Barcelona, Spain
[6] Univ La Laguna, Sch Med, Dept Physiol, Tenerife, Spain
关键词
D O I
10.1212/WNL.62.1_suppl_1.S17
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The severity of dopamine depletion and the consequent pathophysiologic changes that occur in basal ganglia circuits determine the severity of parkinsonian signs. Restoring the dopamine deficit or the downstream physiologic abnormalities improves Parkinson's Disease (PD) main motor features and as a result, attenuates the short-duration response (SDR). Therefore, both the magnitude and duration of the motor response are a function of the degree of motor severity, which is primarily governed by the loss of tonic dopaminergic activity and disruption of basal ganglia homeostatic mechanisms among which the STN-GPe/GPi circuits play a fundamental role. As neurodegeneration advances, standard levodopa administration give rises to wider oscillations in striatal dopamine availability and "pulsatile" stimulation of striatal dopamine receptors becomes predominant. This induces molecular and physiologic changes that further accentuate and aggravate the SDR that sustains motor fluctuations. Treatments capable of providing and restoring more tonic and physiologic dopaminergic stimulation may avoid many of these abnormalities and lead to better clinical outcomes.
引用
收藏
页码:S17 / S30
页数:14
相关论文
共 90 条
[1]   Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study [J].
Aarsland, D ;
Andersen, K ;
Larsen, JP ;
Lolk, A ;
Kragh-Sorensen, P .
ARCHIVES OF NEUROLOGY, 2003, 60 (03) :387-392
[2]   THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J].
ALBIN, RL ;
YOUNG, AB ;
PENNEY, JB .
TRENDS IN NEUROSCIENCES, 1989, 12 (10) :366-375
[3]   Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms [J].
Bézard, E ;
Boraud, T ;
Bioulac, B ;
Gross, CE .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1999, 11 (06) :2167-2170
[4]   Presymptomatic compensation in Parkinson's disease is not dopamine-mediated [J].
Bezard, E ;
Gross, CE ;
Brotchie, JM .
TRENDS IN NEUROSCIENCES, 2003, 26 (04) :215-221
[5]   Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease [J].
Bezard, E ;
Dovero, S ;
Prunier, C ;
Ravenscroft, P ;
Chalon, S ;
Guilloteau, D ;
Crossman, AR ;
Bioulac, B ;
Brotchie, JM ;
Gross, CE .
JOURNAL OF NEUROSCIENCE, 2001, 21 (17) :6853-6861
[6]   Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies [J].
Bezard, E ;
Brotchie, JM ;
Gross, CE .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (08) :577-588
[7]   Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function [J].
Bézard, E ;
Ferry, S ;
Mach, U ;
Stark, H ;
Leriche, L ;
Boraud, T ;
Gross, C ;
Sokoloff, P .
NATURE MEDICINE, 2003, 9 (06) :762-767
[8]  
BIBBIANI F, 2002, NEUROLOGY S, V60, P330
[9]   WEARING-OFF FLUCTUATIONS IN PARKINSONS-DISEASE - CONTRIBUTION OF POSTSYNAPTIC MECHANISMS [J].
BRAVI, D ;
MOURADIAN, MM ;
ROBERTS, JW ;
DAVIS, TL ;
SOHN, YH ;
CHASE, TN .
ANNALS OF NEUROLOGY, 1994, 36 (01) :27-31
[10]   Oscillatory nature of human basal ganglia activity: Relationship to the pathophysiology of Parkinson's disease [J].
Brown, P .
MOVEMENT DISORDERS, 2003, 18 (04) :357-363